drug
enalapril maleate
Marketedupdated 3mo agoby Oceanside Pharmaceuticals Inc
Approvedcommunity read0 votes
indications
investigational
Hypertension
all catalysts(0)
nothing on the calendar yet
Trials studying enalapril maleate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 6, 2032
~6.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (13)
- Mar 25, 2036formulationUS 10039745
- Mar 25, 2036method-of-use (U-1723)US 10154987
- Mar 25, 2036formulationUS 10772868
- Mar 25, 2036formulationUS 10786482
- Mar 25, 2036formulationUS 11040023
- Mar 25, 2036formulationUS 11141405
- Mar 25, 2036formulationUS 11173141
- Mar 25, 2036formulationUS 9669008
- Mar 25, 2036method-of-use (U-3)US 9808442
- Nov 6, 2032formulationUS 8568747
- Nov 6, 2032method-of-use (U-1892)US 8778366
- Nov 6, 2032formulationUS 9855214
- Nov 6, 2032method-of-use (U-1723)US 9968553
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that